Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition

Purpose: The objective of this study was to evaluate adverse events (AEs) in patients who received both immune checkpoint inhibitors and thoracic radiation therapy (RT). In particular, we compared the rate of toxicities of concurrent versus sequential delivery of thoracic RT and checkpoint inhibitor...

Full description

Bibliographic Details
Main Authors: Donata von Reibnitz, BS, Jamie E. Chaft, MD, Abraham J. Wu, MD, Robert Samstein, MD, PhD, Matthew D. Hellmann, MD, Andrew J. Plodkowski, MD, Zhigang Zhang, PhD, Weiji Shi, MS, Rosalind Dick-Godfrey, BS, Kelly H. Panchoo, BA, Christopher A. Barker, MD, Andreas Rimner, MD
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418300794

Internet

http://www.sciencedirect.com/science/article/pii/S2452109418300794

Similar Items